Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Putney

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Antisense & Nucleic Acid Drug Development|November 11, 1999
Enhanced anti-tumor effects with microencapsulated c-myc antisense oligonucleotideS D Putney, J Brown, C Cucco, et al.
Science (New York, N.Y.)|December 14, 1990
Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1K Javaherian, A J Langlois, G J LaRosa, et al.
AIDS Research and Human Retroviruses|January 1, 1987
Prospects for development of a vaccine against HTLV-III-related disordersT J Matthews, H K Lyerly, K J Weinhold, et al.
Journal of Virology|April 1, 1992
Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralizationR J Grimaila, B A Fuller, P D Rennert, et al.
Science (New York, N.Y.)|July 15, 1988
Type-restricted neutralization of molecular clones of human immunodeficiency virusD J Looney, A G Fisher, S D Putney, et al.
Nature Medicine|July 1, 1996
A month-long effect from a single injection of microencapsulated human growth hormoneO L Johnson, J L Cleland, H J Lee, et al.
The Journal of Infectious Diseases|September 1, 1995
Peptide from a prokaryotic adhesin blocks leukocyte migration in vitro and in vivoE Rozdzinski, B Spellerberg, M van der Flier, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1987
Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptideK B Cease, H Margalit, J L Cornette, et al.
Science (New York, N.Y.)|December 8, 1989
A formalin-inactivated whole SIV vaccine confers protection in macaquesM Murphey-Corb, L N Martin, B Davison-Fairburn, et al.
Journal of Virology|August 1, 1990
Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzeesE A Emini, P L Nara, W A Schleif, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Antisense & Nucleic Acid Drug Development|November 11, 1999
Enhanced anti-tumor effects with microencapsulated c-myc antisense oligonucleotideS D Putney, J Brown, C Cucco, et al.
Science (New York, N.Y.)|December 14, 1990
Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1K Javaherian, A J Langlois, G J LaRosa, et al.
AIDS Research and Human Retroviruses|January 1, 1987
Prospects for development of a vaccine against HTLV-III-related disordersT J Matthews, H K Lyerly, K J Weinhold, et al.
Journal of Virology|April 1, 1992
Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralizationR J Grimaila, B A Fuller, P D Rennert, et al.
Science (New York, N.Y.)|July 15, 1988
Type-restricted neutralization of molecular clones of human immunodeficiency virusD J Looney, A G Fisher, S D Putney, et al.
Nature Medicine|July 1, 1996
A month-long effect from a single injection of microencapsulated human growth hormoneO L Johnson, J L Cleland, H J Lee, et al.
The Journal of Infectious Diseases|September 1, 1995
Peptide from a prokaryotic adhesin blocks leukocyte migration in vitro and in vivoE Rozdzinski, B Spellerberg, M van der Flier, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1987
Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptideK B Cease, H Margalit, J L Cornette, et al.
Science (New York, N.Y.)|December 8, 1989
A formalin-inactivated whole SIV vaccine confers protection in macaquesM Murphey-Corb, L N Martin, B Davison-Fairburn, et al.
Journal of Virology|August 1, 1990
Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzeesE A Emini, P L Nara, W A Schleif, et al.
Pageof 5